Form 4 for VRTX Vertex Pharmaceuticals
Accepted 2026-05-05 17:29:42 ET · period of report 2026-05-01 · accession 0000875320-26-000189 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-05 17:29 | 2026-05-01 | VRTX | Schneider Jennifer | Dir | A - Grant | $0.00 | +472 | 2,190 | +27% | $0 |
| D | 2026-05-05 17:29 | 2026-05-01 | VRTX | Schneider Jennifer | Dir | D - Sale to Iss | — | -796 | 1,394 | -36% | — |
| DM | 2026-05-05 17:29 | 2026-05-01 | VRTX | Schneider Jennifer | Dir | A - Grant | $0.00 | +2,229 | 796 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-01 | A | A | 472 | $0.00 | 2,190 | D | — | — | (F1) Restricted stock unit award that vests, subject to certain limited exceptions, on the first anniversary of the grant date. |
| 2 | Common | Common Stock | 2026-05-01 | D | D | 796 | — | 1,394 | D | — | — | (F2) Upon the vesting of restricted stock units granted to Dr. Schneider on May 1, 2025, Dr. Schneider deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Dr. Schneider is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units. |
| 3 | Derivative | Stock Option (Right to Buy) | 2026-05-01 | A | A | 1,433 | $0.00 | 1,433 | D | $424.45 · — to 2036-04-30 | 1,433 Common Stock | (F3) Fully vested. |
| 4 | Derivative | Deferred Stock Units | 2026-05-01 | A | A | 796 | — | 796 | D | — · — to — | 796 Common Stock | (F4) Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Schneider's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Schneider's disability or death. (F2) Upon the vesting of restricted stock units granted to Dr. Schneider on May 1, 2025, Dr. Schneider deferred the receipt of 796 shares of common stock and received instead 796 deferred stock units pursuant to our deferred compensation plan. As a result, Dr. Schneider is reporting the disposition of 796 shares of common stock in exchange for an equal number of deferred stock units. (F4) Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Schneider's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Schneider's disability or death. (F4) Each deferred stock unit represents one share of common stock and is paid out in common stock upon the earliest to occur of (i) termination of Dr. Schneider's service on our board of directors, (ii) a change of control of our company and (iii) Dr. Schneider's disability or death. |